📰 Advamed Code News
Page 2 - Advamed Code News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Advamed Code. Real-time updates on events, politics, business and more.
April 7, 2022
Advanced Medical Technology Association announced its revised Code of Ethics on Interactions with Health Care Professionals. AdvaMed’s revisions provide guidance on technologically enhanced delivery models and novel arrangements, such as those involving value-based care.
March 29, 2022
On March 18, 2022, the Advanced Medical Technology Association (“AdvaMed”) announced revisions to its Code of Ethics on Interactions with Health Care Professionals (“Code”). The revised...
March 24, 2022
On March 18, the Advanced Medical Technology Association (AdvaMed) announced revisions to its Code of Ethics on Interactions with Health Care Professionals (AdvaMed Code or Code), last...
January 6, 2022
Kyle Faget is a special counsel and business lawyer with Foley & Lardner LLP. She is a member of the firm’s Government & Public Policy Practice and the Health Care and Life Sciences Industry Teams.
December 2, 2021
Part 1 of this article series, published in the November 2021 issue of Compliance Today, outlined in general the American and Italian healthcare systems. Part 2 outlines America’s...
November 30, 2021
As the ‘pandemic’ is being viewed in our collective ‘rear view mirrors’, going ahead at full steam seems like the only mantra of most companies, well-established and startups alike. Learnings from 2020-21 setbacks have been taken seriously by the industry at large and the diagnostics and the medtech sector has high hopes for 2022. We explore the expectations and opportunities that are ripe for the picking in the months ahead.
October 27, 2021
The code will provide medical technology and diagnostics makers with compliance principles and guidance
October 21, 2021
Kyle Faget is a special counsel and business lawyer with Foley & Lardner LLP. She is a member of the firm’s Government & Public Policy Practice and the Health Care and Life Sciences Industry Teams.